Treating nicotine dependence by targeting attention-deficit/ hyperactivity disorder (ADHD) with OROS methylphenidate: the role of baseline ADHD severity and treatment response.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Clinical Psychiatry

• Publication date

  2013-10-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.4088/JCP.12m08155PMID 24229749PMCID PMC3946795
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Attention-deficit/hyperactivity disorder (ADHD) symptoms, craving to smoke, and tobacco withdrawal symptoms in adult smokers with ADHD.

  2012cited by this paper
• Tobacco dependence counseling in a randomized multisite clinical trial.

  2012cited by this paper
• Baseline Matters: The Importance of Covariation for Baseline Severity in the Analysis of Clinical Trials

  2011cited by this paper
• Meta-analysis of supplemental treatment for depressive and anxiety disorders in patients being treated for alcohol dependence.

  2011cited by this paper
• Divergence by ADHD subtype in smoking cessation response to OROS-methylphenidate.

  2011cited by this paper
• Course of self-reported symptoms of attention deficit and hyperactivity in substance abusers during early treatment.

  2010cited by this paper
• Antidepressant drug effects and depression severity: a patient-level meta-analysis.

  2010cited by this paper
• OROS-methylphenidate or placebo for adult smokers with attention deficit hyperactivity disorder: racial/ethnic differences.

  2010cited by this paper
• Nicotine addiction.

  2010cited by this paper
• Impact of attention-deficit/hyperactivity disorder (ADHD) treatment on smoking cessation intervention in ADHD smokers: a randomized, double-blind, placebo-controlled trial.

  2010cited by this paper
• Life Impairments in Adults With Medication-Treated ADHD

  2010cited by this paper
• Do treatment improvements in PTSD severity affect substance use outcomes? A secondary analysis from a randomized clinical trial in NIDA's Clinical Trials Network.

  2010cited by this paper
• Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents.

  2008cited by this paper
• Treating Tobacco Use and Dependence: 2008 Update

  2008cited by this paper
• Evidence-based treatments of addiction

  2008cited by this paper
• Smoking cessation and inattention or hyperactivity/impulsivity: a post hoc analysis.

  2008cited by this paper
• A pharmacological analysis of stimulant-induced increases in smoking

  2007cited by this paper
• Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder.

  2007cited by this paper
• Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions.

  2007cited by this paper
• A randomized trial of bupropion and/or nicotine gum as maintenance treatment for preventing smoking relapse.

  2007cited by this paper
• Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

  2007cited by this paper
• Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention.

  2007cited by this paper
• The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication.

  2006cited by this paper
• Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis.

  2005cited by this paper
• Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults.

  2005cited by this paper
• Methylphenidate increases cigarette smoking

  2005cited by this paper
• Preliminary evidence of the association between the history of childhood attention-deficit/hyperactivity disorder and smoking treatment failure.

  2005cited by this paper
• Co-occurring mental and substance use disorders: the neurobiological effects of chronic stress.

  2005cited by this paper
• Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder.

  2004cited by this paper
• Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis.

  2004cited by this paper
• Measures of abstinence in clinical trials: issues and recommendations.

  2003cited by this paper
• Acute effects of d-amphetamine on progressive-ratio performance maintained by cigarette smoking and money

  2003cited by this paper
• Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practiceand problems

  2002cited by this paper
• Acute doses of d-amphetamine and bupropion increase cigarette smoking

  2001cited by this paper
• A review of the pharmacotherapy of adults with Attention-Deficit/ Hyperactivity Disorder

  2001cited by this paper
• d-Amphetamine increases choice of cigarette smoking over monetary reinforcement

  2000cited by this paper
• A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD.

  1999cited by this paper
• Imipramine treatment of opiate-dependent patients with depressive disorders. A placebo-controlled trial.

  1998cited by this paper
• Adhd Rating Scale-IV: Checklists, Norms, and Clinical Interpretation

  1998cited by this paper
• Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD).

  1996cited by this paper
• Imipramine treatment of alcoholics with primary depression: A placebo-controlled clinical trial.

  1996cited by this paper
• Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder.

  1995cited by this paper
• Reanalysis of The National Institute of Mental Health Treatment of Depression Collaborative Research Program General Effectiveness Report

  1993cited by this paper
• The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.

  1991cited by this paper
• Comparison of tests used to distinguish smokers from nonsmokers.

  1987cited by this paper
• The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence.

  1985cited by this paper
• The Self-Medication Hypothesis of Addictive Disorders: Focus on Heroin and Cocaine Dependence

  1985cited by this paper
• Cigarette smoking and subjective response: Effects of d‐amphetamine

  1981cited by this paper
• Phobic anxiety syndrome complicated by drug dependence and addiction. A treatable form of drug abuse.

  1972cited by this paper

• The co-use of nicotine and prescription psychostimulants: A review of their behavioral and neuropharmacological interactions.

  2023cites this paper
• Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.

  2022cites this paper
• Influence of Substance Use Disorder on Treatment Retention of Adult-Attention-Deficit/Hyperactive Disorder Patients. A 5-Year Follow-Up Study

  2021cites this paper
• Systematic Review and Meta-Analysis: Treatment of Substance Use Disorder in Attention Deficit Hyperactivity Disorder.

  2020cites this paper
• Are non-abstinent reductions in World Health Organization drinking risk level a valid treatment target for alcohol use disorders in adolescents with ADHD?

  2020cites this paper
• ADHD Is Highly Prevalent in Patients Seeking Treatment for Cannabis Use Disorders

  2020cites this paper
• Differential posttreatment outcomes of methylphenidate for smoking cessation for individuals With ADHD.

  2019cites this paper
• Pharmacotherapeutic strategies for the treatment of attention-deficit hyperactivity (ADHD) disorder with comorbid substance-use disorder (SUD)

  2018cites this paper
• Exploring longitudinal course and treatment-baseline severity interactions in secondary outcomes of smoking cessation treatment in individuals with attention-deficit hyperactivity disorder

  2018cites this paper
• How treatment improvement in ADHD and cocaine dependence are related to one another: A secondary analysis.

  2018cites this paper
• Causal Factors of Increased Smoking in ADHD: A Systematic Review

  2018cites this paper
• Optimizing clinical trials with Open Trial Chain

  2018cites this paper
• Pharmacological Treatment of ADHD in Addicted Patients: What Does the Literature Tell Us?

  2017cites this paper
• Eficàcia, seguretat i abandonament del tractament farmacològic del trastorn per dèficit d’atenció amb hiperactivitat en pacients adults

  2017cites this paper
• Towards Precision Addiction Treatment: New Findings in Co-morbid Substance Use and Attention-Deficit Hyperactivity Disorders

  2017cites this paper
• The treatment of dual ADHD: a drop in the ocean.

  2016cites this paper
• Effect of adult attention deficit hyperactivity symptoms on smoking cessation

  2016cites this paper
• Nicotine Addiction and Psychiatric Disorders.

  2015cites this paper
• Methylphenidate in Adults with Attention Deficit Hyperactivity Disorder and Substance Use Disorders.

  2015cites this paper
• Toward personalized smoking-cessation treatment: Using a predictive modeling approach to guide decisions regarding stimulant medication treatment of attention-deficit/hyperactivity disorder (ADHD) in smokers.

  2015cites this paper
• A systematic approach to subgroup analyses in a smoking cessation trial

  2015cites this paper
• Predictors of treatment response in adolescents with comorbid substance use disorder and attention-deficit/hyperactivity disorder.

  2013cites this paper